The Medibank Private Ltd (ASX: MPL) share price has travelled modestly over the course of the new year. This comes as the private health insurance giant continues to navigate its way through COVID-19.
At Friday's market close, Medibank shares touched a 52-week high of $3.63 before slightly retracing to $3.60, up 5.88%.
In contrast, the S&P/ASX 200 Index (ASX: XJO) ended the day 1.29% higher at 7,453.3 points.
Investors may be wondering what's ahead for Medibank in 2022. Below, we look at some of the key dates to watch out for.
What's ahead for Medibank in 2022?
Australia's leading health insurance provider recently released its calendar for the 2022 financial year.
The first date of note is just around the corner on 25 February, when Medibank plans to deliver its half-year results for FY22. Along with its six-month performance report, the company will also announce the 2022 interim dividend.
The ex-dividend date for the interim dividend is scheduled for the following week, on 4 March. This is when investors must have purchased Medibank shares to be eligible for the upcoming interim dividend payment.
The payment date for the interim dividend is set for 24 March, when investors will collect a portion of the company's profits.
Medibank handed shareholders a fully franked interim dividend of 5.8 cents per share for the first half of FY21.
The above process will repeat itself with Medibank releasing its full-year results and full-year dividend sometime in August. Although these dates are yet to be released by the company.
Medibank share price snapshot
Based on valuation grounds, Medibank presides a market capitalisation of roughly $9.91 billion, with approximately 2.75 billion shares on issue.
The company currently has a trailing dividend yield of 3.53% and a price-to-earnings (P/E) ratio of 22.50.
